Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I study with the DNA sequence-specific agent adozelesin.
Burris HA, Dieras VC, Tunca M, Earhart RH, Eckardt JR, Rodriguez GI, Shaffer DS, Fields SM, Campbell E, Schaaf L, Kasunic D, Von Hoff DD. Burris HA, et al. Among authors: rodriguez gi. Anticancer Drugs. 1997 Jul;8(6):588-96. doi: 10.1097/00001813-199707000-00006. Anticancer Drugs. 1997. PMID: 9300573 Clinical Trial.
A phase I clinical and pharmacokinetic trial of hepsulfam.
Ravdin PM, Havlin KA, Marshall MV, Brown TD, Koeller JM, Kuhn JG, Rodriguez G, Von Hoff DD. Ravdin PM, et al. Among authors: rodriguez g. Cancer Res. 1991 Dec 1;51(23 Pt 1):6268-72. Cancer Res. 1991. PMID: 1933887 Clinical Trial.
Phase I clinical trial of ormaplatin (tetraplatin, NSC 363812).
O'Rourke TJ, Weiss GR, New P, Burris HA 3rd, Rodriguez G, Eckhardt J, Hardy J, Kuhn JG, Fields S, Clark GM, et al. O'Rourke TJ, et al. Among authors: rodriguez g. Anticancer Drugs. 1994 Oct;5(5):520-6. doi: 10.1097/00001813-199410000-00002. Anticancer Drugs. 1994. PMID: 7858283 Clinical Trial.
A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation.
Rinaldi DA, Kuhn JG, Burris HA, Dorr FA, Rodriguez G, Eckhardt SG, Jones S, Woodworth JR, Baker S, Langley C, Mascorro D, Abrahams T, Von Hoff DD. Rinaldi DA, et al. Among authors: rodriguez g. Cancer Chemother Pharmacol. 1999;44(5):372-80. doi: 10.1007/s002800050992. Cancer Chemother Pharmacol. 1999. PMID: 10501910 Clinical Trial.
New anticancer agents.
Weiss GR, Burris HA 3rd, Eckardt JR, Fields S, O'Rourke T, Rodriguez GI, Rothenberg ML. Weiss GR, et al. Among authors: rodriguez gi. Cancer Chemother Biol Response Modif. 1994;15:130-51. Cancer Chemother Biol Response Modif. 1994. PMID: 7779583 Review. No abstract available.
2,116 results